Prior Bevacizumab and Efficacy of Later Anti-Epidermal Growth Factor Receptor Antibodies in Metastatic Colorectal Cancer. Results From a Large International Registry
Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2018.05.009
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2018
Authors
Publisher
Elsevier BV